跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
S-60
首页
药物
S-60
S-60
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION
CN 105251007 A
申请人: QLT PLUG DELIVERY INC
优先权: 2008
CN
US
5 件公开
SYNOVIAL FLUID SUBSTITUTES
EP 4076553 C0
申请人: IBSA INST BIOCHIMIQUE SA
优先权: 2019
CN
EP
US
WO
4 件公开
Aerosol composition
US 8192723 B2
申请人: HEWSON-HYDE CLAIRE LOUISE
优先权: 2006
US
4 件公开
Compound and organic light emitting device comprising the same
US 12004421 B2
申请人: LG CHEMICAL LTD
优先权: 2018
CN
US
3 件公开
US 12098156 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
3 件公开
US 12686661 B2
申请人: LG CHEMICAL LTD
优先权: 2019
US
3 件公开
US 11380851 B2
申请人: LG CHEMICAL LTD
优先权: 2017
US
US 11370782 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 11778909 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 11787818 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 11680071 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 12389793 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 12453283 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 12060372 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 11873297 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
US 12022730 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME
US 2024251668 A1
申请人: LG CHEMICAL LTD
优先权: 2021
CN
US
3 件公开
NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
US 2024208991 A1
申请人: LG CHEMICAL LTD
优先权: 2021
CN
US
3 件公开
US 2023174544 A1
申请人: LG CHEMICAL LTD
优先权: 2020
CN
US
2 件公开
US 2022402928 A1
申请人: LG CHEMICAL LTD
优先权: 2020
CN
US
2 件公开
US 2022056048 A1
申请人: LG CHEMICAL LTD
优先权: 2018
US
2 件公开
US 2024057477 A1
申请人: LG CHEMICAL LTD
优先权: 2020
US
2 件公开
US 2024147848 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
2 件公开
US 2024109884 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
2 件公开
US 2024349599 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
2 件公开
US 2023242498 A1
申请人: LG CHEMICAL LTD
优先权: 2020
US
US 2023363266 A1
申请人: LG CHEMICAL LTD
优先权: 2020
US
US 20240381763 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 2023406841 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20240357925 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20250127043 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20240365660 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20240324269 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20250160202 A1
申请人: LG CHEMICAL LTD
优先权: 2022
US
US 20240294515 A1
申请人: LG CHEMICAL LTD
优先权: 2022
US
US 20250318428 A1
申请人: LG CHEMICAL LTD
优先权: 2023
US
US 20250255178 A1
申请人: LG CHEMICAL LTD
优先权: 2023
US
US 20250040428 A1
申请人: LG CHEMICAL LTD
优先权: 2023
US
US 20250143180 A1
申请人: LG CHEMICAL LTD
优先权: 2023
US
US 20260070893 A1
申请人: LG CHEMICAL LTD
优先权: 2024
US
VOC-free compressed gas aerosol compositions
US 8158108 B2
申请人: VALPEY III RICHARD S
优先权: 2007
US
3 件公开
Heterocyclic compound and organic light emitting device comprising the same
US 11903311 B2
申请人: LG CHEMICAL LTD
优先权: 2016
US
3 件公开
US 12250879 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
2 件公开
US 11925113 B2
申请人: LG CHEMICAL LTD
优先权: 2018
US
Organic light emitting device
US 12509464 B2
申请人: LG CHEMICAL LTD
优先权: 2019
US
3 件公开
US 2024107884 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
2 件公开
US 2024081148 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
2 件公开
US 2024215441 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
2 件公开
US 12492191 B2
申请人: LG CHEMICAL LTD
优先权: 2019
US
US 2023086039 A1
申请人: LG CHEMICAL LTD
优先权: 2020
US
US 11588116 B2
申请人: LG CHEMICAL LTD
优先权: 2020
US
US 20240349605 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20240381766 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20240407257 A1
申请人: LG CHEMICAL LTD
优先权: 2021
US
US 20250040435 A1
申请人: LG CHEMICAL LTD
优先权: 2023
US
RECOMBINANT HEPATITIS C VIRUS GLYCOPROTEINS, COMPOSITION AND APPLICATION(S) THEREOF
EP 4801549 A1
申请人: STICHTING AMSTERDAM UMC
优先权: 2023
EP
WO
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈